IL6 and plasma cell myeloma: Furthermore, a high-affinity fully humanized anti-interleukin 6 monoclonal antibody (mAb 1339) is available and has shown in vitro and in vivo antimultiple myeloma activity, both alone and in combination with conventional and novel agents against multiple myeloma [64].